Thursday, September 29, 2022

Gold Trims Weekly Decline as Rising Virus Cases, Vaccine Weighed By Bloomberg


© Reuters. Gold Trims Weekly Decline as Rising Virus Cases, Vaccine Weighed

(Bloomberg) — rose, paring a weekly drop, as investors weighed a resurgence of cases in the U.S. and major European economies and the prospects for coronavirus vaccines.

New York Mayor Bill de Blasio said the city was ready for the possibility of closing its schools again, while California passed 1 million infections. In Europe, France and the U.K. reported the most infections yet, and Portugal extended restrictions. Even with the prospect of a Covid-19 vaccine, three of the world’s top central bankers, including Federal Reserve Chairman Jerome Powell, cautioned that a vaccine would not end the economic challenges.

In the coming quarters, factors supporting gold include low bond yields, a weakening dollar due to loose fiscal and monetary policy, and geopolitical tensions, according to Fitch Solutions. In 2021, the metal’s gains will be limited by a limited recovery and the rising odds of a vaccine approval, and prices are forecast to average $1,850 an ounce, it said in a report.

“Gold has turned mixed as support from rising virus risks, mixed economic data from major economies, hopes of additional stimulus measures is countered by weaker investor buying, progress on a vaccine and concerns about U.S. fiscal stimulus deal,” said Madhavi Mehta, an analyst at Kotak Securities Ltd. However, the outlook for gold remains positive amid increasing virus risks, which makes a case for continuing stimulus measures, she said.

rose 0.2% to $1,879.73 an ounce at 6:44 a.m. in London, after climbing 0.6% on Thursday. Prices are down 3.6% this week. was little changed. The Bloomberg Dollar Spot Index was steady after two days of gains.


Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Source link


Please enter your comment!
Please enter your name here



Related Stories